0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acellular Dermal Matrix (ADM) Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-3Y18194
Home | Market Reports | Beauty & Fitness| Cosmetic Procedures
Global Acellular Dermal Matrix ADM Market Research Report 2024
BUY CHAPTERS

Global Acellular Dermal Matrix (ADM) Market Research Report 2026

Code: QYRE-Auto-3Y18194
Report
2026-02-11
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Acellular Dermal Matrix (ADM) Market

The global Acellular Dermal Matrix (ADM) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Acellular Dermal Matrix (ADM) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Acellular Dermal Matrix (ADM) is a biomaterial used in various surgical procedures, derived from human or animal skin tissue that has been processed to remove all cells, leaving behind a matrix of collagen and elastin fibers. This matrix serves as a scaffold to support tissue regeneration and healing by allowing the patient's own cells to populate and grow into the structure. ADM is commonly used in reconstructive surgeries, such as breast reconstruction, hernia repairs, and wound healing, because it provides structural support and promotes integration with the surrounding tissue. The acellular nature of the matrix reduces the risk of immune rejection and inflammatory responses, making it a versatile and effective tool in modern surgical practices​​.
The North American market for Acellular Dermal Matrix (ADM) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Acellular Dermal Matrix (ADM) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Acellular Dermal Matrix (ADM) include AlloDerm (AbbVie), Zimmer Biomet, Stryker, DeCell Technologies, MatriDerm, MTF Biologics, Smith+Nephew, Medtronic, RTI Surgical, Straumann, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Acellular Dermal Matrix (ADM) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Acellular Dermal Matrix (ADM). The Acellular Dermal Matrix (ADM) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Acellular Dermal Matrix (ADM) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Acellular Dermal Matrix (ADM) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Acellular Dermal Matrix (ADM) Market Report

Report Metric Details
Report Name Acellular Dermal Matrix (ADM) Market
Segment by Type
  • Allogeneic ADM (Human Origin)
  • Xenogeneic ADM (Animal Origin)
by Application
  • Tissue Repair
  • Plastic Surgery
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AlloDerm (AbbVie), Zimmer Biomet, Stryker, DeCell Technologies, MatriDerm, MTF Biologics, Smith+Nephew, Medtronic, RTI Surgical, Straumann, AlloSource, Unitrump, Lthink
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Acellular Dermal Matrix (ADM) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Acellular Dermal Matrix (ADM) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Acellular Dermal Matrix (ADM) Market report?

Ans: The main players in the Acellular Dermal Matrix (ADM) Market are AlloDerm (AbbVie), Zimmer Biomet, Stryker, DeCell Technologies, MatriDerm, MTF Biologics, Smith+Nephew, Medtronic, RTI Surgical, Straumann, AlloSource, Unitrump, Lthink

What are the Application segmentation covered in the Acellular Dermal Matrix (ADM) Market report?

Ans: The Applications covered in the Acellular Dermal Matrix (ADM) Market report are Tissue Repair, Plastic Surgery, Others

What are the Type segmentation covered in the Acellular Dermal Matrix (ADM) Market report?

Ans: The Types covered in the Acellular Dermal Matrix (ADM) Market report are Allogeneic ADM (Human Origin), Xenogeneic ADM (Animal Origin)

1 Acellular Dermal Matrix (ADM) Market Overview
1.1 Product Definition
1.2 Acellular Dermal Matrix (ADM) by Type
1.2.1 Global Acellular Dermal Matrix (ADM) Market Value by Type: 2025 vs 2032
1.2.2 Allogeneic ADM (Human Origin)
1.2.3 Xenogeneic ADM (Animal Origin)
1.3 Acellular Dermal Matrix (ADM) by Application
1.3.1 Global Acellular Dermal Matrix (ADM) Market Value by Application: 2025 vs 2032
1.3.2 Tissue Repair
1.3.3 Plastic Surgery
1.3.4 Others
1.4 Global Acellular Dermal Matrix (ADM) Market Size Estimates and Forecasts
1.4.1 Global Acellular Dermal Matrix (ADM) Revenue 2021–2032
1.4.2 Global Acellular Dermal Matrix (ADM) Sales 2021–2032
1.4.3 Global Acellular Dermal Matrix (ADM) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Acellular Dermal Matrix (ADM) Market Competition by Manufacturers
2.1 Global Acellular Dermal Matrix (ADM) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Acellular Dermal Matrix (ADM) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Acellular Dermal Matrix (ADM) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Acellular Dermal Matrix (ADM), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Acellular Dermal Matrix (ADM), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Acellular Dermal Matrix (ADM), Product Types and Applications
2.7 Global Key Manufacturers of Acellular Dermal Matrix (ADM), Date of Entry into the Industry
2.8 Global Acellular Dermal Matrix (ADM) Market Competitive Situation and Trends
2.8.1 Global Acellular Dermal Matrix (ADM) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Acellular Dermal Matrix (ADM) Players Market Share by Revenue
2.8.3 Global Acellular Dermal Matrix (ADM) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Acellular Dermal Matrix (ADM) Market Scenario by Region
3.1 Global Acellular Dermal Matrix (ADM) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Acellular Dermal Matrix (ADM) Sales by Region: 2021–2032
3.2.1 Global Acellular Dermal Matrix (ADM) Sales by Region: 2021–2026
3.2.2 Global Acellular Dermal Matrix (ADM) Sales by Region: 2027–2032
3.3 Global Acellular Dermal Matrix (ADM) Revenue by Region: 2021–2032
3.3.1 Global Acellular Dermal Matrix (ADM) Revenue by Region: 2021–2026
3.3.2 Global Acellular Dermal Matrix (ADM) Revenue by Region: 2027–2032
3.4 North America Acellular Dermal Matrix (ADM) Market Facts & Figures by Country
3.4.1 North America Acellular Dermal Matrix (ADM) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Acellular Dermal Matrix (ADM) Sales by Country (2021–2032)
3.4.3 North America Acellular Dermal Matrix (ADM) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Acellular Dermal Matrix (ADM) Market Facts & Figures by Country
3.5.1 Europe Acellular Dermal Matrix (ADM) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Acellular Dermal Matrix (ADM) Sales by Country (2021–2032)
3.5.3 Europe Acellular Dermal Matrix (ADM) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acellular Dermal Matrix (ADM) Market Facts & Figures by Region
3.6.1 Asia Pacific Acellular Dermal Matrix (ADM) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Acellular Dermal Matrix (ADM) Sales by Region (2021–2032)
3.6.3 Asia Pacific Acellular Dermal Matrix (ADM) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Acellular Dermal Matrix (ADM) Market Facts & Figures by Country
3.7.1 Latin America Acellular Dermal Matrix (ADM) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Acellular Dermal Matrix (ADM) Sales by Country (2021–2032)
3.7.3 Latin America Acellular Dermal Matrix (ADM) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Acellular Dermal Matrix (ADM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Acellular Dermal Matrix (ADM) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Acellular Dermal Matrix (ADM) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Acellular Dermal Matrix (ADM) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acellular Dermal Matrix (ADM) Sales by Type (2021–2032)
4.1.1 Global Acellular Dermal Matrix (ADM) Sales by Type (2021–2026)
4.1.2 Global Acellular Dermal Matrix (ADM) Sales by Type (2027–2032)
4.1.3 Global Acellular Dermal Matrix (ADM) Sales Market Share by Type (2021–2032)
4.2 Global Acellular Dermal Matrix (ADM) Revenue by Type (2021–2032)
4.2.1 Global Acellular Dermal Matrix (ADM) Revenue by Type (2021–2026)
4.2.2 Global Acellular Dermal Matrix (ADM) Revenue by Type (2027–2032)
4.2.3 Global Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2021–2032)
4.3 Global Acellular Dermal Matrix (ADM) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Acellular Dermal Matrix (ADM) Sales by Application (2021–2032)
5.1.1 Global Acellular Dermal Matrix (ADM) Sales by Application (2021–2026)
5.1.2 Global Acellular Dermal Matrix (ADM) Sales by Application (2027–2032)
5.1.3 Global Acellular Dermal Matrix (ADM) Sales Market Share by Application (2021–2032)
5.2 Global Acellular Dermal Matrix (ADM) Revenue by Application (2021–2032)
5.2.1 Global Acellular Dermal Matrix (ADM) Revenue by Application (2021–2026)
5.2.2 Global Acellular Dermal Matrix (ADM) Revenue by Application (2027–2032)
5.2.3 Global Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2021–2032)
5.3 Global Acellular Dermal Matrix (ADM) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AlloDerm (AbbVie)
6.1.1 AlloDerm (AbbVie) Company Information
6.1.2 AlloDerm (AbbVie) Description and Business Overview
6.1.3 AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Product Portfolio
6.1.5 AlloDerm (AbbVie) Recent Developments/Updates
6.2 Zimmer Biomet
6.2.1 Zimmer Biomet Company Information
6.2.2 Zimmer Biomet Description and Business Overview
6.2.3 Zimmer Biomet Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Zimmer Biomet Acellular Dermal Matrix (ADM) Product Portfolio
6.2.5 Zimmer Biomet Recent Developments/Updates
6.3 Stryker
6.3.1 Stryker Company Information
6.3.2 Stryker Description and Business Overview
6.3.3 Stryker Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Stryker Acellular Dermal Matrix (ADM) Product Portfolio
6.3.5 Stryker Recent Developments/Updates
6.4 DeCell Technologies
6.4.1 DeCell Technologies Company Information
6.4.2 DeCell Technologies Description and Business Overview
6.4.3 DeCell Technologies Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 DeCell Technologies Acellular Dermal Matrix (ADM) Product Portfolio
6.4.5 DeCell Technologies Recent Developments/Updates
6.5 MatriDerm
6.5.1 MatriDerm Company Information
6.5.2 MatriDerm Description and Business Overview
6.5.3 MatriDerm Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MatriDerm Acellular Dermal Matrix (ADM) Product Portfolio
6.5.5 MatriDerm Recent Developments/Updates
6.6 MTF Biologics
6.6.1 MTF Biologics Company Information
6.6.2 MTF Biologics Description and Business Overview
6.6.3 MTF Biologics Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 MTF Biologics Acellular Dermal Matrix (ADM) Product Portfolio
6.6.5 MTF Biologics Recent Developments/Updates
6.7 Smith+Nephew
6.7.1 Smith+Nephew Company Information
6.7.2 Smith+Nephew Description and Business Overview
6.7.3 Smith+Nephew Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Smith+Nephew Acellular Dermal Matrix (ADM) Product Portfolio
6.7.5 Smith+Nephew Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Company Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Medtronic Acellular Dermal Matrix (ADM) Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 RTI Surgical
6.9.1 RTI Surgical Company Information
6.9.2 RTI Surgical Description and Business Overview
6.9.3 RTI Surgical Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 RTI Surgical Acellular Dermal Matrix (ADM) Product Portfolio
6.9.5 RTI Surgical Recent Developments/Updates
6.10 Straumann
6.10.1 Straumann Company Information
6.10.2 Straumann Description and Business Overview
6.10.3 Straumann Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Straumann Acellular Dermal Matrix (ADM) Product Portfolio
6.10.5 Straumann Recent Developments/Updates
6.11 AlloSource
6.11.1 AlloSource Company Information
6.11.2 AlloSource Description and Business Overview
6.11.3 AlloSource Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 AlloSource Acellular Dermal Matrix (ADM) Product Portfolio
6.11.5 AlloSource Recent Developments/Updates
6.12 Unitrump
6.12.1 Unitrump Company Information
6.12.2 Unitrump Description and Business Overview
6.12.3 Unitrump Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Unitrump Acellular Dermal Matrix (ADM) Product Portfolio
6.12.5 Unitrump Recent Developments/Updates
6.13 Lthink
6.13.1 Lthink Company Information
6.13.2 Lthink Description and Business Overview
6.13.3 Lthink Acellular Dermal Matrix (ADM) Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Lthink Acellular Dermal Matrix (ADM) Product Portfolio
6.13.5 Lthink Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acellular Dermal Matrix (ADM) Industry Chain Analysis
7.2 Acellular Dermal Matrix (ADM) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acellular Dermal Matrix (ADM) Production Mode & Process Analysis
7.4 Acellular Dermal Matrix (ADM) Sales and Marketing
7.4.1 Acellular Dermal Matrix (ADM) Sales Channels
7.4.2 Acellular Dermal Matrix (ADM) Distributors
7.5 Acellular Dermal Matrix (ADM) Customer Analysis
8 Acellular Dermal Matrix (ADM) Market Dynamics
8.1 Acellular Dermal Matrix (ADM) Industry Trends
8.2 Acellular Dermal Matrix (ADM) Market Drivers
8.3 Acellular Dermal Matrix (ADM) Market Challenges
8.4 Acellular Dermal Matrix (ADM) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Acellular Dermal Matrix (ADM) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Acellular Dermal Matrix (ADM) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Acellular Dermal Matrix (ADM) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Acellular Dermal Matrix (ADM) Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Acellular Dermal Matrix (ADM) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Acellular Dermal Matrix (ADM) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Acellular Dermal Matrix (ADM) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Acellular Dermal Matrix (ADM), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Acellular Dermal Matrix (ADM), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Acellular Dermal Matrix (ADM), Product Types and Applications
 Table 12. Global Key Manufacturers of Acellular Dermal Matrix (ADM), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Acellular Dermal Matrix (ADM) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Acellular Dermal Matrix (ADM) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Acellular Dermal Matrix (ADM) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Acellular Dermal Matrix (ADM) Sales by Region (K Units), 2021–2026
 Table 18. Global Acellular Dermal Matrix (ADM) Sales Market Share by Region (2021–2026)
 Table 19. Global Acellular Dermal Matrix (ADM) Sales by Region (K Units), 2027–2032
 Table 20. Global Acellular Dermal Matrix (ADM) Sales Market Share by Region (2027–2032)
 Table 21. Global Acellular Dermal Matrix (ADM) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2021–2026)
 Table 23. Global Acellular Dermal Matrix (ADM) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2027–2032)
 Table 25. North America Acellular Dermal Matrix (ADM) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2021–2026
 Table 27. North America Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2027–2032
 Table 28. North America Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Acellular Dermal Matrix (ADM) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2021–2026
 Table 32. Europe Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2027–2032
 Table 33. Europe Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Acellular Dermal Matrix (ADM) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Acellular Dermal Matrix (ADM) Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Acellular Dermal Matrix (ADM) Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Acellular Dermal Matrix (ADM) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Acellular Dermal Matrix (ADM) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Acellular Dermal Matrix (ADM) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2021–2026
 Table 42. Latin America Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2027–2032
 Table 43. Latin America Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Acellular Dermal Matrix (ADM) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Acellular Dermal Matrix (ADM) Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Acellular Dermal Matrix (ADM) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Acellular Dermal Matrix (ADM) Sales (K Units) by Type (2021–2026)
 Table 51. Global Acellular Dermal Matrix (ADM) Sales (K Units) by Type (2027–2032)
 Table 52. Global Acellular Dermal Matrix (ADM) Sales Market Share by Type (2021–2026)
 Table 53. Global Acellular Dermal Matrix (ADM) Sales Market Share by Type (2027–2032)
 Table 54. Global Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2021–2026)
 Table 57. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2027–2032)
 Table 58. Global Acellular Dermal Matrix (ADM) Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Acellular Dermal Matrix (ADM) Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Acellular Dermal Matrix (ADM) Sales (K Units) by Application (2021–2026)
 Table 61. Global Acellular Dermal Matrix (ADM) Sales (K Units) by Application (2027–2032)
 Table 62. Global Acellular Dermal Matrix (ADM) Sales Market Share by Application (2021–2026)
 Table 63. Global Acellular Dermal Matrix (ADM) Sales Market Share by Application (2027–2032)
 Table 64. Global Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2021–2026)
 Table 67. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2027–2032)
 Table 68. Global Acellular Dermal Matrix (ADM) Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Acellular Dermal Matrix (ADM) Price (US$/Unit) by Application (2027–2032)
 Table 70. AlloDerm (AbbVie) Company Information
 Table 71. AlloDerm (AbbVie) Description and Business Overview
 Table 72. AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Product
 Table 74. AlloDerm (AbbVie) Recent Developments/Updates
 Table 75. Zimmer Biomet Company Information
 Table 76. Zimmer Biomet Description and Business Overview
 Table 77. Zimmer Biomet Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Zimmer Biomet Acellular Dermal Matrix (ADM) Product
 Table 79. Zimmer Biomet Recent Developments/Updates
 Table 80. Stryker Company Information
 Table 81. Stryker Description and Business Overview
 Table 82. Stryker Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Stryker Acellular Dermal Matrix (ADM) Product
 Table 84. Stryker Recent Developments/Updates
 Table 85. DeCell Technologies Company Information
 Table 86. DeCell Technologies Description and Business Overview
 Table 87. DeCell Technologies Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. DeCell Technologies Acellular Dermal Matrix (ADM) Product
 Table 89. DeCell Technologies Recent Developments/Updates
 Table 90. MatriDerm Company Information
 Table 91. MatriDerm Description and Business Overview
 Table 92. MatriDerm Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. MatriDerm Acellular Dermal Matrix (ADM) Product
 Table 94. MatriDerm Recent Developments/Updates
 Table 95. MTF Biologics Company Information
 Table 96. MTF Biologics Description and Business Overview
 Table 97. MTF Biologics Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. MTF Biologics Acellular Dermal Matrix (ADM) Product
 Table 99. MTF Biologics Recent Developments/Updates
 Table 100. Smith+Nephew Company Information
 Table 101. Smith+Nephew Description and Business Overview
 Table 102. Smith+Nephew Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Smith+Nephew Acellular Dermal Matrix (ADM) Product
 Table 104. Smith+Nephew Recent Developments/Updates
 Table 105. Medtronic Company Information
 Table 106. Medtronic Description and Business Overview
 Table 107. Medtronic Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Medtronic Acellular Dermal Matrix (ADM) Product
 Table 109. Medtronic Recent Developments/Updates
 Table 110. RTI Surgical Company Information
 Table 111. RTI Surgical Description and Business Overview
 Table 112. RTI Surgical Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. RTI Surgical Acellular Dermal Matrix (ADM) Product
 Table 114. RTI Surgical Recent Developments/Updates
 Table 115. Straumann Company Information
 Table 116. Straumann Description and Business Overview
 Table 117. Straumann Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Straumann Acellular Dermal Matrix (ADM) Product
 Table 119. Straumann Recent Developments/Updates
 Table 120. AlloSource Company Information
 Table 121. AlloSource Description and Business Overview
 Table 122. AlloSource Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. AlloSource Acellular Dermal Matrix (ADM) Product
 Table 124. AlloSource Recent Developments/Updates
 Table 125. Unitrump Company Information
 Table 126. Unitrump Description and Business Overview
 Table 127. Unitrump Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Unitrump Acellular Dermal Matrix (ADM) Product
 Table 129. Unitrump Recent Developments/Updates
 Table 130. Lthink Company Information
 Table 131. Lthink Description and Business Overview
 Table 132. Lthink Acellular Dermal Matrix (ADM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Lthink Acellular Dermal Matrix (ADM) Product
 Table 134. Lthink Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Acellular Dermal Matrix (ADM) Distributors List
 Table 138. Acellular Dermal Matrix (ADM) Customers List
 Table 139. Acellular Dermal Matrix (ADM) Market Trends
 Table 140. Acellular Dermal Matrix (ADM) Market Drivers
 Table 141. Acellular Dermal Matrix (ADM) Market Challenges
 Table 142. Acellular Dermal Matrix (ADM) Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Acellular Dermal Matrix (ADM)
 Figure 2. Global Acellular Dermal Matrix (ADM) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Acellular Dermal Matrix (ADM) Market Share by Type: 2025 & 2032
 Figure 4. Allogeneic ADM (Human Origin) Product Picture
 Figure 5. Xenogeneic ADM (Animal Origin) Product Picture
 Figure 6. Global Acellular Dermal Matrix (ADM) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Acellular Dermal Matrix (ADM) Market Share by Application: 2025 & 2032
 Figure 8. Tissue Repair
 Figure 9. Plastic Surgery
 Figure 10. Others
 Figure 11. Global Acellular Dermal Matrix (ADM) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Acellular Dermal Matrix (ADM) Market Size (US$ Million), 2021–2032
 Figure 13. Global Acellular Dermal Matrix (ADM) Sales (K Units), 2021–2032
 Figure 14. Global Acellular Dermal Matrix (ADM) Average Price (US$/Unit), 2021–2032
 Figure 15. Acellular Dermal Matrix (ADM) Report Years Considered
 Figure 16. Acellular Dermal Matrix (ADM) Sales Share by Manufacturers in 2025
 Figure 17. Global Acellular Dermal Matrix (ADM) Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Acellular Dermal Matrix (ADM) Players: Market Share by Revenue in Acellular Dermal Matrix (ADM) in 2025
 Figure 19. Acellular Dermal Matrix (ADM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Acellular Dermal Matrix (ADM) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Acellular Dermal Matrix (ADM) Sales Market Share by Country (2021–2032)
 Figure 22. North America Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2021–2032)
 Figure 23. United States Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Acellular Dermal Matrix (ADM) Sales Market Share by Country (2021–2032)
 Figure 26. Europe Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Acellular Dermal Matrix (ADM) Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2021–2032)
 Figure 34. China Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Acellular Dermal Matrix (ADM) Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Acellular Dermal Matrix (ADM) Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Acellular Dermal Matrix (ADM) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Acellular Dermal Matrix (ADM) by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Acellular Dermal Matrix (ADM) by Type (2021–2032)
 Figure 54. Global Acellular Dermal Matrix (ADM) Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Acellular Dermal Matrix (ADM) by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Acellular Dermal Matrix (ADM) by Application (2021–2032)
 Figure 57. Global Acellular Dermal Matrix (ADM) Price (US$/Unit) by Application (2021–2032)
 Figure 58. Acellular Dermal Matrix (ADM) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI